Neurogene Statistics
NASDAQ: NGNEHealthcareBiotechnologyUSD
26.50+0.63 (+2.44%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Neurogene by the numbers
Neurogene has a market capitalization of $530.3 million based on 20.01M shares outstanding. With trailing EPS of $-5.04, Neurogene is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 22.7% below its 50-day average and 3.0% below its 200-day average.
Average daily trading volume is 245.99K shares, or about $6.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NGNE valuation vs. peer median
| Metric | NGNE | Peer median | Difference |
|---|---|---|---|
| Market cap | $530.30M | $555.44M | -5% |
| Avg. volume | 245.99K | 1.26M | -80% |
Peer median across 8 companies: RGNX, PHAT, SLN, RZLT, NVCT, OABI, SCTX, OBIO.
Valuation
- Market cap
- $530.30M
- EPS (TTM)
- $-5.04
- Shares outstanding
- 20.01M
Price and trading
- Previous close
- 25.87
- Open
- 28.00
- Day range
- 26.24 – 28.97
- 52-week range
- 15.93 – 43.66
- 52-week change
- +2.59%
- Beta
- —
- Volume
- 508.28K
- Average volume
- 245.99K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2026
Additional statistics
- Market Cap
- 530.30M
- Forward Pe
- -4.66
- Eps
- -5.04
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 43.66
- Week52 Low
- 15.93
- Avg Volume
- 245.99K
- Shares Outstanding
- 20.01M
- Ma50
- 34.26
- Ma200
- 27.32
- Earnings Date
- Aug 11, 2026
- Pct From52w High
- -39.30%
- Pct From52w Low
- 66.35%